Cormedix Inc (CRMD) Stock Price, Quote & News

Company Profile

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was in...

Industry: Biotechnology

Sector: Healthcare

Phone: 908 517 9500

Website: cormedix.com

Address:

389 Interpace Pkwy, Suite 450, Parsippany, United States

Comeasuare Jul. 15 at 1:56 AM

$CRMD only two people texting a hundred times a day enuff already. new rule one text allowed per day, so the 22,000 watchers don’t get bored.

1 · Reply

Mr_Pithy Jul. 15 at 12:15 AM

$CRMD RED DOMINATES THE CHART. EXTREMELY BEARISH SENTIMENT. SELL AND MOVE ON? EYES WIDE OPEN.

0 · Reply

Derek22us Jul. 14 at 7:25 PM

$CRMD Stuck in a cesspool of ask dropping ignorant trading trash.

0 · Reply

CRMDespair Jul. 14 at 3:09 PM

$CRMD Volume is so dried up I don’t even think shorts want to mess with this one.

2 · Reply

Andy1063 Jul. 14 at 2:29 PM

$CRMD

0 · Reply

CRMDespair Jul. 14 at 2:20 PM

$TLPH $CRMD You thought this being tied to Joe Todisco was a good thing?

0 · Reply

CRMDespair Jul. 14 at 1:32 PM

$CRMD Oof again.

0 · Reply

wolfofwestloop Jul. 14 at 1:21 PM

$CRMD Maybe one day we will get some updates. Next ER should be in 4-5 weeks. Hopefully they don't pull a surprise call where they give 4-5 hours notice.

0 · Reply

SweStonk Jul. 14 at 9:34 AM

$CRMD Look at our revenue, our mkt cap and our pipeline! Nuf.

3 · Reply

Mr_Pithy Jul. 14 at 1:16 AM

$CRMD LOOK AT THE CHART. LOOK AT THE SENTIMENT. NUF’ SAID.

0 · Reply

CorMedix price target lowered to $13 from $14 at RBC Capital

Jun 23, 2026, 9:00 AM EDT - 21 days ago

CorMedix Transcript: AGM 2026

2026-06-08T13:00:11.000Z - 5 weeks ago

CorMedix announces United States Court of Appeals affirms patent judgements

Jun 8, 2026, 8:30 AM EDT - 5 weeks ago

U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation

Jun 3, 2026, 4:20 PM EDT - 5 weeks ago

CorMedix Transcript: Jefferies Global Healthcare Conference 2026

May 22, 2026, 7:00 AM EDT - 7 weeks ago

CorMedix Slides: Corporate presentation

May 20, 2026, 11:00 AM EDT - 7 weeks ago

CorMedix Transcript: RBC Capital Markets Global Healthcare Conference 2026

May 15, 2026, 8:30 AM EDT - 2 months ago

Cormedix Therapeutics to Participate in two Upcoming Investor Conferences

May 14, 2026, 8:30 AM EDT - 2 months ago

CorMedix Earnings Call Transcript: Q1 2026

May 14, 2026, 8:30 AM EDT - 2 months ago

CorMedix Earnings release: Q1 2026

May 14, 2026, 8:30 AM EDT - 2 months ago

CorMedix Quarterly report: Q1 2026

2026-05-14T11:53:51.000Z - 2 months ago

CorMedix reports Q1 EPS 43c, consensus 33c

2026-05-14T11:47:54.000Z - 2 months ago

CorMedix raises FY26 revenue view to $325M-$345M from $300M-$320M

May 14, 2026, 7:30 AM EDT - 2 months ago

Cormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

May 5, 2026, 8:30 AM EDT - 2 months ago

CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026

Apr 29, 2026, 8:00 AM EDT - 2 months ago

CorMedix Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

CorMedix Proxy statement: Proxy filing

2026-04-28T19:40:19.000Z - 2 months ago

Citizens healthcare analysts hold an analyst/industry conference call

2026-04-28T11:56:23.000Z - 2 months ago

CorMedix price target raised to $14 from $13 at RBC Capital

2026-04-27T12:05:37.000Z - 2 months ago

CorMedix announces ReSPECT clinical trial met primary endpoint

Apr 27, 2026, 7:30 AM EDT - 2 months ago

CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients

Apr 17, 2026, 8:00 AM EDT - 3 months ago

CorMedix Proxy statement: Proxy filing

Apr 14, 2026, 3:00 PM EDT - 3 months ago

CorMedix Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 7, 2026, 8:30 AM EDT - 3 months ago

CorMedix to Participate in Needham Virtual Healthcare Conference

Mar 11, 2026, 9:35 AM EDT - 4 months ago

CorMedix Transcript: The Citizens Life Sciences Conference 2026

Mar 10, 2026, 1:00 PM EDT - 4 months ago

CorMedix Transcript: Leerink Global Healthcare Conference 2026

Mar 7, 2026, 6:00 AM EST - 4 months ago

CorMedix Slides: Corporate presentation

2026-03-06T22:20:58.000Z - 4 months ago

CorMedix affirms FY26 revenue view of $300M-$320M, consensus $308.7M

2026-03-06T17:05:52.000Z - 4 months ago

CorMedix price target lowered to $13 from $15 at Leerink

Mar 5, 2026, 12:58 PM EST - 4 months ago

CorMedix stock drops after earnings: is this dip a buy before key catalyst?

Mar 5, 2026, 8:30 AM EST - 4 months ago

CorMedix Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 4 months ago

CorMedix Annual report: Q4 2025

Mar 5, 2026, 8:30 AM EST - 4 months ago

CorMedix Earnings release: Q4 2025

2026-03-05T12:36:24.000Z - 4 months ago

CorMedix reports Q4 EPS 16c vs 20c last year

Mar 5, 2026, 7:30 AM EST - 4 months ago

CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Mar 2, 2026, 8:30 AM EST - 4 months ago

CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026

Feb 12, 2026, 8:30 AM EST - 5 months ago

CorMedix to Participate in Upcoming Investor Conferences

Feb 10, 2026, 1:00 PM EST - 5 months ago

CorMedix Transcript: Investor Day 2026

Feb 10, 2026, 1:00 PM EST - 5 months ago

CorMedix Slides: FY 2026

2026-02-02T13:35:15.000Z - 5 months ago

CorMedix board authorizes share repurchase program of up to $75M

Feb 2, 2026, 8:30 AM EST - 5 months ago

CorMedix Therapeutics Announces Share Repurchase Program

Jan 29, 2026, 8:30 AM EST - 5 months ago

CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026

2026-01-23T11:10:42.000Z - 6 months ago

CorMedix price target lowered to $13 from $18 at H.C. Wainwright

2026-01-21T11:35:46.000Z - 6 months ago

CorMedix price target lowered to $13 from $22 at RBC Capital

Jan 12, 2026, 7:30 PM EST - 6 months ago

CorMedix Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 10, 2026, 7:00 AM EST - 6 months ago

CorMedix Slides: Corporate presentation

Jan 9, 2026, 8:30 AM EST - 6 months ago

CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Jan 8, 2026, 1:37 PM EST - 6 months ago

Why is CorMedix stock crashing today: is it worth buying on the dip?

2026-01-08T17:45:22.000Z - 6 months ago

CorMedix price target lowered to $16 from $20 at Truist

Jan 8, 2026, 8:05 AM EST - 6 months ago

CorMedix Therapeutics Announces Leadership and Board Updates

Jan 8, 2026, 8:00 AM EST - 6 months ago

CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates

Dec 18, 2025, 8:00 AM EST - 7 months ago

CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath

Nov 12, 2025, 4:05 PM EST - 8 months ago

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

TLPH

Nov 12, 2025, 8:30 AM EST - 8 months ago

CorMedix Earnings Call Transcript: Q3 2025

Nov 12, 2025, 8:30 AM EST - 8 months ago

CorMedix Quarterly report: Q3 2025

Nov 12, 2025, 8:30 AM EST - 8 months ago

CorMedix Earnings release: Q3 2025

Nov 12, 2025, 7:30 AM EST - 8 months ago

CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance

Oct 31, 2025, 8:30 AM EDT - 9 months ago

CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025

Oct 24, 2025, 8:00 AM EDT - 9 months ago

CorMedix Proxy statement: Proxy Filing

Oct 23, 2025, 8:30 AM EDT - 9 months ago

CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath

Oct 22, 2025, 4:05 PM EDT - 9 months ago

Halper Sadeh LLC Encourages CorMedix Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 20, 2025, 9:42 AM EDT - 9 months ago

CRMD, RANI, CELC, RAPT: four biotech stocks flying high today and why

CELC RANI RAPT

Oct 20, 2025, 7:30 AM EDT - 9 months ago

CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance

Oct 14, 2025, 8:00 AM EDT - 9 months ago

CorMedix Proxy statement: Proxy Filing

Sep 30, 2025, 8:00 AM EDT - 10 months ago

CorMedix Registration statement: Registration Filing

Sep 29, 2025, 8:30 AM EDT - 10 months ago

CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO

Sep 15, 2025, 8:00 AM EDT - 10 months ago

CorMedix Proxy statement: Proxy Filing

Sep 10, 2025, 10:45 AM EDT - 10 months ago

CorMedix Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 8, 2025, 8:30 AM EDT - 11 months ago

CorMedix Announces Strategic Minority Investment in Talphera

TLPH

Sep 8, 2025, 8:30 AM EDT - 11 months ago

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

TLPH

Sep 5, 2025, 8:35 AM EDT - 11 months ago

CorMedix Transcript: Cantor Global Healthcare Conference 2025

Sep 2, 2025, 7:30 AM EDT - 11 months ago

CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team

Aug 7, 2025, 10:49 AM EDT - 1 year ago

CorMedix to Buy Melinta Therapeutics for $300 Million

Aug 7, 2025, 7:30 AM EDT - 1 year ago

CorMedix Quarterly report: Q2 2025

Aug 7, 2025, 7:30 AM EDT - 1 year ago

CorMedix Earnings release: Q2 2025

Aug 7, 2025, 7:10 AM EDT - 1 year ago

Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry Leadership

Aug 7, 2025, 7:00 AM EDT - 1 year ago

CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings

Aug 7, 2025, 7:00 AM EDT - 1 year ago

Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

Jun 27, 2025, 8:00 AM EDT - 1 year ago

CorMedix Inc. Announces Pricing of Public Offering of Common Stock

Jun 26, 2025, 4:01 PM EDT - 1 year ago

CorMedix Inc. Announces Proposed Public Offering of Common Stock

Jun 23, 2025, 7:30 AM EDT - 1 year ago

CorMedix inc. Announces Customer Implementation

Jun 5, 2025, 3:45 PM EDT - 1 year ago

CorMedix Transcript: Jefferies Global Healthcare Conference 2025

May 30, 2025, 8:30 AM EDT - 1 year ago

CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference

May 21, 2025, 3:05 PM EDT - 1 year ago

CorMedix Transcript: RBC Capital Markets Global Healthcare Conference 2025

May 15, 2025, 8:30 AM EDT - 1 year ago

CorMedix Inc. to Participate in the RBC Global Healthcare Conference

May 8, 2025, 11:00 AM EDT - 1 year ago

CorMedix Transcript: The Citizens JMP Life Sciences Conference 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

CorMedix Earnings Call Transcript: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

CorMedix Quarterly report: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

CorMedix Earnings release: Q1 2025

May 6, 2025, 7:30 AM EDT - 1 year ago

CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

Apr 29, 2025, 8:30 AM EDT - 1 year ago

CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025

Apr 28, 2025, 8:00 AM EDT - 1 year ago

CorMedix Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

CorMedix Proxy statement: Proxy Filing

Apr 8, 2025, 2:15 PM EDT - 1 year ago

CorMedix Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 8, 2025, 7:30 AM EDT - 1 year ago

Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance

Apr 2, 2025, 8:30 AM EDT - 1 year ago

CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

Comeasuare Jul. 15 at 1:56 AM

$CRMD only two people texting a hundred times a day enuff already. new rule one text allowed per day, so the 22,000 watchers don’t get bored.

1 · Reply

Mr_Pithy Jul. 15 at 12:15 AM

$CRMD RED DOMINATES THE CHART. EXTREMELY BEARISH SENTIMENT. SELL AND MOVE ON? EYES WIDE OPEN.

0 · Reply

Derek22us Jul. 14 at 7:25 PM

$CRMD Stuck in a cesspool of ask dropping ignorant trading trash.

0 · Reply

CRMDespair Jul. 14 at 3:09 PM

$CRMD Volume is so dried up I don’t even think shorts want to mess with this one.

2 · Reply

Andy1063 Jul. 14 at 2:29 PM

$CRMD

0 · Reply

CRMDespair Jul. 14 at 2:20 PM

$TLPH $CRMD You thought this being tied to Joe Todisco was a good thing?

0 · Reply

CRMDespair Jul. 14 at 1:32 PM

$CRMD Oof again.

0 · Reply

wolfofwestloop Jul. 14 at 1:21 PM

$CRMD Maybe one day we will get some updates. Next ER should be in 4-5 weeks. Hopefully they don't pull a surprise call where they give 4-5 hours notice.

0 · Reply

SweStonk Jul. 14 at 9:34 AM

$CRMD Look at our revenue, our mkt cap and our pipeline! Nuf.

3 · Reply

Mr_Pithy Jul. 14 at 1:16 AM

$CRMD LOOK AT THE CHART. LOOK AT THE SENTIMENT. NUF’ SAID.

0 · Reply

ZacksResearch Jul. 13 at 6:42 PM

$CRMD Gains 17% in Six Months 👀 Can the Momentum Sustain on DefenCath? See what Wall Street expects next 👉 https://www.zacks.com/stock/research/CRMD/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-38768&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_38768

2 · Reply

CRMDespair Jul. 13 at 5:58 PM

$CRMD $QQQ $SPY $XBI

0 · Reply

CRMDespair Jul. 13 at 4:57 PM

$CRMD $QQQ $SPY $XBI

0 · Reply

CRMDespair Jul. 13 at 4:36 PM

$CRMD If you have something new and positive to say, by all means, please say it. Not as a reply to this, but as its own message. I’ll wait. Don’t be shy.

1 · Reply

Derek22us Jul. 13 at 4:11 PM

$CRMD Small lot trading idiots setting the share price. Unfortunately, when you invest in a publicly traded stock, you get into a flea infested bed of dumb and dumber trading trash.

0 · Reply

CRMDespair Jul. 13 at 4:09 PM

$CRMD Feel free to share your loss porn. Thanks Joe Todisco! $XBI $QQQ $SPY

0 · Reply

flabb Jul. 13 at 3:28 PM

$HOOD very interesting postiion at 110.67 i added a few times from 109 - 111.00 If i get buying power, i will be adding. but in the meantime adding $CRMD $BA and searching for more opportunities.

0 · Reply

flabb Jul. 13 at 3:23 PM

$CRMD i am just so ready for her to pop over 9.00 and hold around 9.85 and higher.

0 · Reply

GardeningGirl Jul. 13 at 3:09 PM

$CRMD

2 · Reply

gorditacrunchbis Jul. 13 at 2:10 PM

$CRMD oh yeah we were totally trending, so much so we are still sub 80k volume. What a scam stock

0 · Reply

CRMDespair Jul. 13 at 1:59 PM

$CRMD $SPY

0 · Reply

CRMDespair Jul. 13 at 1:46 PM

$CRMD Dave Ramsey is 100% right. Never invest in a single stock.

2 · Reply

Market Cap	652.72M
Revenue (ttm)	311.71M
Net Income (ttm)	163.06M
EPS (ttm)	N/A
PE Ratio	4.44
Forward PE	16.47
Profit Margin	52.31%
Debt to Equity Ratio	0.00

Volume	806,800
Avg Vol	1,393,664
Day's Range	N/A - N/A
Shares Out	78.45M
Stochastic %K	29%
Beta	1.48
Analysts	Strong Sell
Price Target	$13.86